QT Imaging (NASDAQ:QTI – Get Free Report) is anticipated to announce its Q2 2026 results before the market opens on Thursday, August 6th. Analysts expect the company to announce earnings of ($0.22) per share and revenue of $7.60 million for the quarter. Investors are encouraged to explore the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Friday, August 14, 2026 at 9:30 AM ET.
QT Imaging (NASDAQ:QTI – Get Free Report) last released its earnings results on Wednesday, May 13th. The company reported ($0.25) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.11). The business had revenue of $6.53 million for the quarter, compared to analyst estimates of $6.45 million. QT Imaging had a negative net margin of 58.93% and a negative return on equity of 4,220.38%. On average, analysts expect QT Imaging to post $-1 EPS for the current fiscal year and $-0 EPS for the next fiscal year.
QT Imaging Trading Up 3.6%
Shares of NASDAQ QTI traded up $0.10 during mid-day trading on Tuesday, hitting $2.73. The company’s stock had a trading volume of 10,087 shares, compared to its average volume of 44,137. QT Imaging has a one year low of $1.55 and a one year high of $8.50. The company’s fifty day simple moving average is $3.73 and its 200-day simple moving average is $5.29. The company has a debt-to-equity ratio of 1.38, a current ratio of 2.49 and a quick ratio of 1.69. The stock has a market cap of $37.52 million, a price-to-earnings ratio of -2.20 and a beta of -0.01.
Analysts Set New Price Targets
Check Out Our Latest Research Report on QT Imaging
About QT Imaging
QT Imaging Ltd. (NASDAQ: QTI) is a medical technology company specializing in the development and commercialization of advanced ultrasound imaging solutions. The company focuses on real-time volumetric imaging systems designed to enhance diagnostic capabilities in obstetrics, gynecology and other clinical applications. QT Imaging’s flagship Q.VIEW® system and associated software suite enable practitioners to capture, analyze and visualize high-resolution 3D/4D ultrasound images, offering improved workflow efficiency and enhanced patient care.
QT Imaging’s product portfolio includes proprietary transducers, imaging consoles and software platforms that can be integrated with existing ultrasound scanners from leading original equipment manufacturers.
Featured Stories
- Five stocks we like better than QT Imaging
- GLP-1 Demand Is Creating a New Dividend Angle in These 4 Logistics Stocks
- Tether Strikes Gold: Crypto’s Physical Pivot
- Jersey Mike’s Serves Fresh Gains After IPO Stumble
- 3 Drone Stocks That Should Soar After the Summer Slump
Receive News & Ratings for QT Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for QT Imaging and related companies with MarketBeat.com's FREE daily email newsletter.
